Trichloroacetic Acid for Endoscopic Tracho-esophageal Fistula Repair

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT01287312

Enrollment

Registered

2011-02-01

Start date

2011-01-31

Completion date

2013-01-31

Last updated

2011-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tracheo Esophageal Fistula

Keywords

We will treat children age 1 month to 20 years with recurrent TEF after surgical failure

Brief summary

Today Endoscopic repair of recurrent Tracheesophageal fistula (TEF) is a safe procedure. Using Trichlosiacetic acid 50% (TCA) for endoscopic aplication of the fistula was reported with a good results ( 4 cases). There were no serious advers effects. The investigators want to use also TCA 50% for endoscopic repair in children with recurrent TEF.

Detailed description

Today Endoscopic repair of recurrent Tracheesophageal fistula (TEF) is a safe procedure. Using Trichlosiacetic acid 50% (TCA) for endoscopic aplication of the fistula was reported with a good results ( 4 cases). There were no serious advers effects. We want to use also TCA 50% for endoscopic repair in children with recurrent TEF.

Interventions

PROCEDUREEndoscopic repair of recurrent TEF by trichloroacetic acid aplications

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

1 Months to 20 Years

Healthy volunteers

Inclusion criteria

* children age 1 month- 20 years old with recurrent TEF. * Failure of surgical repair.

Design outcomes

Primary

Measure	Time frame	Description
Closure of the fistula	—	Closure of the fistula

Secondary

Measure	Time frame
clinical and pulmonary improvment	—

Countries

Israel

Contacts

Primary Contactshlomo cohen, MD

shlomoco@hadassah.org.il+972 2 6776817

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026